Novacek G - Search Results

1

Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel disease.

Kutschera M, Waldhör T, Gröchenig HP, Haas T, Wenzl H, Steiner P, Koch R, Feichtenschlager T, Eckhardt G, Mayer A, Kirchgatterer A, Ludwiczek O, Platzer R, Papay P, Gartner J, Fuchssteiner H, Peters PG, Reicht G, Moser G, Dejaco C, Vogelsang H, Primas C, Novacek G, Miehsler W; Austrian IBD Study Group. Kutschera M, et al. Among authors: novacek g. United European Gastroenterol J. 2021 Feb;9(1):72-81. doi: 10.1177/2050640620946874. Epub 2021 Feb 18. United European Gastroenterol J. 2021. PMID: 32723070 Free PMC article.

2

Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study.

Novacek G, Kleinberger M, Vogelsang H, Moser G, Lochs H. Novacek G, et al. Z Gastroenterol. 1995 May;33(5):251-4. Z Gastroenterol. 1995. PMID: 7610692

3

Course of pseudocholinesterase isozymes during an acute phase in Crohn's disease.

Novacek G, Reinisch W, Vogelsang H, Kapiotis S, Gmeiner B. Novacek G, et al. Digestion. 1996;57(2):90-4. doi: 10.1159/000201319. Digestion. 1996. PMID: 8786006

4

Changes in blood rheology caused by Crohn's disease.

Novacek G, Vogelsang H, Genser D, Moser G, Gangl A, Ehringer H, Koppensteiner R. Novacek G, et al. Eur J Gastroenterol Hepatol. 1996 Nov;8(11):1089-93. doi: 10.1097/00042737-199611000-00011. Eur J Gastroenterol Hepatol. 1996. PMID: 8944371

5

Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease.

Oberhuber G, Püspök A, Oesterreicher C, Novacek G, Zauner C, Burghuber M, Vogelsang H, Pötzi R, Stolte M, Wrba F. Oberhuber G, et al. Among authors: novacek g. Gastroenterology. 1997 Mar;112(3):698-706. doi: 10.1053/gast.1997.v112.pm9041230. Gastroenterology. 1997. PMID: 9041230

6

The relationship between juxtapapillary duodenal diverticula and biliary stone disease.

Novacek G, Walgram M, Bauer P, Schöfl R, Gangl A, Pötzi R. Novacek G, et al. Eur J Gastroenterol Hepatol. 1997 Apr;9(4):375-9. doi: 10.1097/00042737-199704000-00011. Eur J Gastroenterol Hepatol. 1997. PMID: 9160201

7

Increased gastric and intestinal permeability in patients with Crohn's disease.

Wyatt J, Oberhuber G, Pongratz S, Püspök A, Moser G, Novacek G, Lochs H, Vogelsang H. Wyatt J, et al. Among authors: novacek g. Am J Gastroenterol. 1997 Oct;92(10):1891-6. Am J Gastroenterol. 1997. PMID: 9382060

8

No evidence of activated blood coagulation in Crohn's disease.

Novacek G, Kapiotis S, Moser G, Speiser W, Gangl A, Vogelsang H. Novacek G, et al. Eur J Gastroenterol Hepatol. 1997 Oct;9(10):963-7. doi: 10.1097/00042737-199710000-00008. Eur J Gastroenterol Hepatol. 1997. PMID: 9391785

9

[Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].

Dejaco C, Gasché C, Reinisch W, Moser G, Novacek G, Tillinger W, Vogelsang H, Gangl A. Dejaco C, et al. Among authors: novacek g. Wien Klin Wochenschr. 1998 Sep 4;110(16):579-84. Wien Klin Wochenschr. 1998. PMID: 9782579 German.

10

Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease.

Novacek G, Miehsler W, Kapiotis S, Katzenschlager R, Speiser W, Vogelsang H. Novacek G, et al. Am J Gastroenterol. 1999 Mar;94(3):685-90. doi: 10.1111/j.1572-0241.1999.00937.x. Am J Gastroenterol. 1999. PMID: 10086652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page